tiprankstipranks
Trending News
More News >
Immunicum AB (DE:1YG0)
FRANKFURT:1YG0
Germany Market
Advertisement

Immunicum AB (1YG0) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

1YG0 Financial Forecast

1YG0 Earnings Forecast

The previous quarter’s earnings for 1YG0 were -€0.06.
The previous quarter’s earnings for 1YG0 were -€0.06.

1YG0 Sales Forecast

The previous quarter’s earnings for 1YG0 were €0.00.
The previous quarter’s earnings for 1YG0 were €0.00.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

1YG0 Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.

1YG0 Stock Forecast FAQ

What is DE:1YG0’s average 12-month price target, according to analysts?
Based on analyst ratings, Immunicum AB’s 12-month average price target is 0.67.
    What is DE:1YG0’s upside potential, based on the analysts’ average price target?
    Immunicum AB has 8.06% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Immunicum AB a Buy, Sell or Hold?
          Immunicum AB has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Immunicum AB’s share price target?
            The average share price target for Immunicum AB is 0.67. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €0.67 ,and the lowest forecast is €0.67. The average share price target represents 8.06% Increase from the current price of €0.62.
              What do analysts say about Immunicum AB?
              Immunicum AB’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of Immunicum AB?
                To buy shares of DE:1YG0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis